Pergolide

• Description :

  Pergolide (LY127809 (free base) ) is an ergot-derived orally active dopamine receptor agonist. Pergolide can be used for Parkinson disease research[1].

• Product Name Alternative :

  LY127809 (free base)

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Dopamine Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/pergolide.html

• Purity :

  98.59

• Solubility :

  DMSO : 4.17 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles :

  [H][C@@]1(N(CCC)C[C@H](CSC)C[C@@]12[H])CC3=CNC4=CC=CC2=C43

• Molecular Formula :

  C19H26N2S

• Molecular Weight :

  314.49

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Van Camp G, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet. 2004 Apr 10;363 (9416) :1179-83.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [66104-22-1]